Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Sunday share tips: Judges Scientific, Sureserve

(Sharecast News) - Investors in Judges Scientific should hold on to a "decent" amount of their shares in the company, even if they may be tempted to take some profits now at 8,500.0p, the Financial Mail on Sunday's Midas column said. The scientific instruments business should continued to reward them, the tipster argued, not least thanks to the steady head of its long-serving chief executive officer, David Cicurel.

Midas first recommended the shares to its readers in 2012, when they were trading at 745p and brokers believe they could hit 9,500p in coming months.

Judges had 18 technologically advanced firms in its stable which it was helping to grow, helping to boost its 2021 sales by 14% to £91.3m, profits by 21% to £18.1m and its dividend by a fifth to 66p a share.

Analysts retain faith in the business and predict more growth in 2023 and beyond.

The Sunday Times's Lucy Tobin told readers to buy shares of Sureserve, the asset and energy support services group.

While deserving of a "large warning label" for investors, the AIM-listed tiddler was likely to benefit from the increasing prominence of sustainability for both builders and landlords.

Among its areas of business were the servicing of gas and electricity supplies in social housing, installing smart meters and crafting sustainable energy plans for hospitals, libraries and crematoria.

Its order book jumped by half over the six months to March to reach £512m and nearly all its 2022 revenues were already covered by orders.

It also had relationships with local authority customers that gave it valuable visibility over minimum future revenues.

The company's shares had declined 12% year-to-date after management flagged the likely hit to margins from from rising inflation.

Furthermore, it remained to be seen how higher wages, as well as for materials and fuels would narrow its margins.

Nonetheless, analyst Andrew Nussey recently pointed out how Sureserve was set to close the year with £22m of net cash which it could deploy on acquisitions, thanks to strong cash generation in the back half of the year.

Don't bet your house on it - or even your upcoming winter heating bill - but Sureserve is a buy.

Share this article

Related Sharecast Articles

Thursday newspaper round-up: Thames Water, mortgage costs, UK car production
(Sharecast News) - Thames Water has breached its licence to supply water to nearly 16 million people after some of its debt was downgraded to junk status. The regulator Ofwat could now fine Thames, the country's largest water monopoly, up to 10% of its annual turnover, equating to hundreds of millions of pounds. However, since the company is already teetering close to temporary renationalisation, Ofwat is likely to hold off on any immediate large fines. - Guardian
Wednesday newspaper round-up: Reckitt, Tesla, Virgin Atlantic...
(Sharecast News) - Reckitt is under pressure from top shareholders to revisit a sale of its nutrition business, following litigation and a series of other setbacks at the division that have sent the company's share price to decade lows. The FTSE 100 consumer giant acquired the Mead Johnson infant formula business in 2017 for $17bn - its largest-ever acquisition - and it has been plagued by mishaps ever since. Meanwhile, the wider group, which makes Lysol detergent and Durex condoms, has underwhelmed investors as it struggles to build back sales volumes following a period of high inflation and suppressed consumer demand. - Financial Times
Tuesday newspaper round-up: Kamala Harris, Crowdstrike, Vivendi...
(Sharecast News) - Kamala Harris has secured enough delegates from her party to clinch the Democratic presidential nomination, as she pledged to offer Americans a "brighter future" compared to the "chaos, fear and hate" proposed by Donald Trump. The US vice-president was speaking in Wilmington, Delaware, on Monday, the first full day since President Joe Biden dropped his re-election bid and endorsed her for the Democratic presidential nomination, shaking up the 2024 race for the White House. - Financial Times
Monday newspaper round-up: Biden, gambling levy, UK economy...
(Sharecast News) - Kamala Harris, the vice-president, has emerged as the frontrunner to replace President Biden as the Democratic nominee for the election against Donald Trump in November. Biden, 81, announced yesterday afternoon that he would drop out of the race. In the hours that followed, Harris, 59, was endorsed by leading Democrats, prospective rivals and the chairs of all 50 state parties. - The Times

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.